aging age related disorders regeneron pharmaceuticals tarrytown new york cautioned space atrophy different earth based forms nonetheless lee hope blockers myostatin activin preserve restore muscle ground physiologist christoph handschin university basel switzerland agrees adds caveat looks super promising translated humans handschin notes drug companies tried treat people compounds interfere myostatin success lee optimistic suspects blocking myostatin people not sufficient hopes compounds like decoy receptor engage activin prove effective earlier compounds glass says avoid effects important design medication unlikely interact molecules myostatin activin decoy supporting human space travel not lee main goal molecule catch nasa interest agency probably not room extensive